Publicaciones en las que colabora con FRANCISCO MARTÍN MOLINA (33)

2023

  1. Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells

    Molecular Therapy - Nucleic Acids, Vol. 32, pp. 322-339

  2. Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi

    Molecular Therapy Nucleic Acids, Vol. 34

2022

  1. Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma

    Frontiers in Immunology, Vol. 13

  2. Erratum: Physiological lentiviral vectors for the generation of improved CAR-T cells (Molecular Therapy - Oncolytics (2022) 25 (335–349), (S2372770522000687), (10.1016/j.omto.2022.05.003))

    Molecular Therapy - Oncolytics

  3. Physiological lentiviral vectors for the generation of improved CAR-T cells

    Molecular Therapy - Oncolytics, Vol. 25, pp. 335-349

2021

  1. Baboon Envelope Pseudotyped “Nanoblades” Carrying Cas9/gRNA Complexes Allow Efficient Genome Editing in Human T, B, and CD34+ Cells and Knock-in of AAV6-Encoded Donor DNA in CD34+ Cells

    Frontiers in Genome Editing, Vol. 3

  2. Exosomes: Their role in pathogenesis, diagnosis and treatment of diseases

    Cancers, Vol. 13, Núm. 1, pp. 1-45

  3. Improved functionality of integration-deficient lentiviral vectors (IDLVs) by the inclusion of IS2 protein docks

    Pharmaceutics, Vol. 13, Núm. 8

2020

  1. Development of Cellular Models to Study Efficiency and Safety of Gene Edition by Homologous Directed Recombination Using the CRISPR/Cas9 System

    Cells, Vol. 9, Núm. 6

  2. Exosome: A new player in translational nanomedicine

    Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-27

  3. Externally-Controlled Systems for Immunotherapy: From Bench to Bedside

    Frontiers in Immunology, Vol. 11

  4. Genome-edited adult stem cells: Next-generation advanced therapy medicinal products

    Stem Cells Translational Medicine, Vol. 9, Núm. 6, pp. 674-685

  5. Proceedings From the First International Workshop at Sidra Medicine: “Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development”, 15th–16th February 2019, Doha, Qatar

    Frontiers in Immunology, Vol. 11

  6. Using Gene Editing Approaches to Fine-Tune the Immune System

    Frontiers in Immunology, Vol. 11

2019

  1. Stable genetic modification of mesenchymal stromal cells using lentiviral vectors

    Methods in Molecular Biology (Humana Press Inc.), pp. 267-280

2018

  1. Comparison of Zinc Finger Nucleases Versus CRISPR-Specific Nucleases for Genome Editing of the Wiskott-Aldrich Syndrome Locus

    Human Gene Therapy, Vol. 29, Núm. 3, pp. 366-380

  2. The IS2 Element Improves Transcription Efficiency of Integration-Deficient Lentiviral Vector Episomes

    Molecular Therapy - Nucleic Acids, Vol. 13, pp. 16-28

2017

  1. Gene therapy with mesenchymal stem cells expressing IFN-ß ameliorates neuroinflammation in experimental models of multiple sclerosis

    British Journal of Pharmacology, Vol. 174, Núm. 3, pp. 238-253

2016

  1. Absence of WASp enhances hematopoietic and megakaryocytic differentiation in a human embryonic stem cell model

    Molecular Therapy, Vol. 24, Núm. 2, pp. 342-353

  2. Biased and unbiased methods for the detection of off-target cleavage by CRISPR/Cas9: An overview

    International Journal of Molecular Sciences, Vol. 17, Núm. 9